You are not currently logged in.
Access JSTOR through your library or other institution:
Randomized Dose Range Study of a Recombinant Hepatitis B Vaccine Produced in Mammalian Cells and Containing the S and PreS2 Sequences
François Tron, Françoise Degos, Christian Bréchot, Anne-Marie Couroucé, Alain Goudeau, Francois-Noël Marie, Phillippe Adamowicz, Pierre Saliou, Agnès Laplanche, Jean-Pierre Benhamou and Marc Girard
The Journal of Infectious Diseases
Vol. 160, No. 2 (Aug., 1989), pp. 199-204
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30122881
Page Count: 6
You can always find the topics here!Topics: Vaccination, Hepatitis antigens, Antibodies, Hepatitis B virus, Antibody formation, Inoculation, Men, Hepatitis B vaccines, Side effects, Dosage
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
The safety and immunogenicity of different doses (2, 5,10, and 20 µg) of a recombinant hepatitis B virus (rHBV) vaccine containing the S and PreS2 sequences and produced in mammalian cells were compared to those of a plasma-derived hepatitis B virus vaccine (Hevac B Pasteur) in 482 volunteers. Local and general side effects were mild and transient. No transaminase level elevation and autoantibody production were observed. The antibody to hepatitis B surface antigen (HBsAg) seroconversion rates did not differ in the groups receiving the rHBV vaccine and the subjects receiving the plasma-derived vaccine. Both vaccines elicited levels of antibodies to HBsAg in gt;90% of the participants. Geometric mean titers of antibodies to HBsAg induced by the 10- and 20-µg doses of the rHBV vaccine did not differ from that induced by the plasma-derived vaccine and were higher than those induced by the 2- and 5-µg rHBV vaccine doses. The striking feature of the rHBV vaccine compared to the plasma-derived vaccine was an early and high production of antibodies to PreS2, which may constitute an advantage in prevention of hepatitis B virus infection.
The Journal of Infectious Diseases © 1989 Oxford University Press